|
[2-(4-acetylanilino)-2-oxoethyl]phosphonic acid |
|
Bacillus |
Collagenase |
Preclinical (in vivo) |
Alhayek A, et al. 2022. Adv Ther (Weinh) |
|
Bio8B6 |
Depiction based on curated SMILES
HO
Cl
Cl
H
3
C
N
Cl
O
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Gauthier A, et al. 2005. Antimicrob Agents Chemother |
|
1-(3,4-dichlorophenyl)-2-[2-imino-3-(2-piperidin-1-ium-1-ylethyl)benzimidazol-1-yl]ethanone |
Depiction based on curated SMILES
Cl
Cl
O
HN
N
N
H
+
N
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE |
Depiction based on curated SMILES
O
S
O
O
NH
N
S
Br
OH
Br
O
CH
3
S
O
O
NH
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Beresford NJ, et al. 2009. J Antimicrob Chemother |
|
3-((S)-2-(3-benzoyl-1-cyanoindolizin-5-yloxy)-4-methylpentanamido)-3-phenylpropanoic acid |
Depiction based on curated SMILES
N
O
O
N
CH
3
H
O
N
H
H
3
C
O
OH
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Weide T, et al. 2006. Bioorg Med Chem Lett |
|
3-(2-(4-((3-benzoyl-1-cyanoindolizin-5-yl)methoxy)phenyl)-4-methylpentanamido)-3-phenylpropanoic acid |
Depiction based on curated SMILES
N
O
NH
O
O
OH
CH
3
O
H
3
C
N
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Weide T, et al. 2006. Bioorg Med Chem Lett |
|
3-[2-(4-ethoxyphenyl)-2-oxoethyl]-3-hydroxy-1,3-dihydro-2H-indol-2-one |
Depiction based on curated SMILES
OH
HN
O
H
3
C
O
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
Compound 5784 (internal name in literature) |
Depiction based on curated SMILES
+
N
O
_
O
N
O
+
Na
O
CH
3
O
N
H
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
Compound 5816 (internal name in literature) |
Depiction based on curated SMILES
N
N
N
O
+
Na
H
3
C
N
H
O
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
Aspermytin A |
Depiction based on curated SMILES
HO
H
3
C
HO
O
H
3
C
CH
3
H
H
H
|
Staphylococcus |
FnBPs (Fibronectin binding proteins) |
Preclinical (in vitro) |
Park SC, et al. 2020. Mar Drugs |
|
| | |